Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from BML ( (JP:4694) ).
BML, Inc. reported a significant improvement in its financial performance for the first six months of fiscal 2025, with a 6% increase in net sales and a 23.1% rise in profit attributable to owners of the parent compared to the same period in the previous year. The company also announced a dividend increase, reflecting its robust financial health and commitment to shareholder returns.
The most recent analyst rating on (JP:4694) stock is a Buy with a Yen4095.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.
More about BML
BML, Inc. is a company listed on the Tokyo Stock Exchange, primarily operating in the industry of providing medical and healthcare-related services. The company focuses on delivering diagnostic and laboratory services, catering to a wide range of healthcare needs.
Average Trading Volume: 71,218
Technical Sentiment Signal: Buy
Current Market Cap: Yen135.4B
For an in-depth examination of 4694 stock, go to TipRanks’ Overview page.